[1] Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al., Heart disease and stroke statistics -2013 update: a report from the American Heart Association, Circulation, 2013, 127, e6-e245 Google Scholar

[2] Donnan G.A., Fisher M., Macleod M., Davis S.M., Stroke, Lancet, 2008, 371, 1612-1623 Google Scholar

[3] Hankey G.J., Eikelboom J.W., Homocysteine and stroke, Curr. Opin. Neurol., 2001, 14, 95-102 CrossrefGoogle Scholar

[4] Boysen G., Brander T., Christensen H., Gideon R., Truelsen T., Homocysteine and risk of recurrent stroke, Stroke, 2003, 34, 1258- 1261 CrossrefGoogle Scholar

[5] Ji Y., Tan S., Xu Y., Chandra A., Shi C, Song B., Qin J., et al., Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis, Neurology, 2013, 81, 1298-1307 Web of ScienceGoogle Scholar

[6] Hankey G.J., Eikelboom J.W., Loh K., Yi Q., Pizzi J., Tang M., et al., Is there really a power shortage in clinical trials testing the “homocysteine hypothesis?”, Arterioscler. Thromb. Vasc. Biol., 2004, 24, e147 CrossrefGoogle Scholar

[7] Dusitanond P., Eikelboom J.W., Hankey G.J., Thom J., Gilmore G., Loh K., et al., Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial, Stroke, 2005, 36, 144-146 Google Scholar

[8] Ho G.Y., Eikelboom J.W., Hankey G.J., Wong C.R., Tan S.L., Chan J.B., et al., Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients, Stroke, 2006, 37, 456-460 CrossrefGoogle Scholar

[9] VITATOPS Trial Study Group, B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial, Lancet Neurol., 2010, 9, 855-865 Google Scholar

[10] Hankey G.J., Eikelboom J.W., Yi Q., Lees K.R., Chen C., Xavier D., et al., Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial, Lancet Neurol., 2012, 11, 512-520 CrossrefGoogle Scholar

[11] Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G., Measuring inconsistency in meta-analyses, BMJ, 2003, 327, 557-560 Google Scholar

[12] Guyatt G.H., Oxman A.D., Kunz R., Woodcock J., Brozek J., Helfand M., et al., GRADE guidelines: 7. Rating the quality of evidence - inconsistency, J. Clin. Epidemiol., 2011, 64, 1294-1302 Web of ScienceGoogle Scholar

[13] Sterne J.A., Egger M., Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis, J. Clin. Epidemiol., 2001, 54, 1046-1055 Google Scholar

[14] Egger M., Davey Smith G., Schneider M., Minder C., Bias in metaanalysis detected by a simple, graphical test, BMJ, 1997, 315, 629-634 Google Scholar

[15] Gommans J., Yi Q., Eikelboom J.W., Hankey G.J., Chen C., Rodgers H., et al., The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial, BMC Geriatr., 2013, 13, 88 Web of ScienceGoogle Scholar

[16] Hankey G.J., Eikelboom J.W., Loh K., Tang M., Pizzi J., Thom J., et al., Sustained homocysteine-lowering effect over time of folic acidbased multivitamin therapy in stroke patients despite increasing folate status in the population, Cerebrovasc. Dis., 2005, 19, 110-116 CrossrefGoogle Scholar

[17] Hankey G.J., Ford A.H., Yi Q., Eikelboom J.W., Lees K.R., Chen C., et al., Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebocontrolled trial and meta-analysis, Stroke, 2013, 44, 2232-2239 Web of ScienceGoogle Scholar

[18] Potter K., Lenzo N., Eikelboom J.W., Arnolda L.F., Beer C., Hankey G.J., Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebocontrolled trial, Cerebrovasc. Dis., 2009, 27, 259-265 Web of ScienceCrossrefGoogle Scholar

[19] Xia X.S., Li X., Wang L., Wang J.Z., Ma J.P., Wu C.J., Supplementation of folic acid and vitamin B12 reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke, J. Clin. Neurosci., 2014, 21, 1586-1590 Web of ScienceCrossrefGoogle Scholar

[20] Almeida O.P., Marsh K., Alfonso H., Flicker L., Davis T.M., Hankey G.J., B-vitamins reduce the long-term risk of depression after stroke: the VITATOPS-DEP trial, Ann. Neurol., 2010, 68, 503-510 Web of ScienceGoogle Scholar

[21] Arshi B., Ovbiagele B., Markovic D., Saposnik G., Towfighi A., Differential effect of B-vitamin therapy by antiplatelet use on risk of recurrent vascular events after stroke, Stroke, 2015, 46, 870-873 Web of ScienceGoogle Scholar

[22] Coull B.M., Malinow M.R., Beamer N., Sexton G., Nordt F., de Garmo P., Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke, Stroke, 1990, 21, 572-576 CrossrefGoogle Scholar

[23] El Kossi M.M., Zakhary M.M., Oxidative stress in the context of acute cerebrovascular stroke, Stroke, 2000, 31, 1889-1892 CrossrefGoogle Scholar

[24] Brattström L.E., Hardebo J.E., Hultberg B.L., Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease, Stroke, 1984, 15, 1012-1016 CrossrefGoogle Scholar

[25] Perry I.J., Refsum H., Morris R.W., Ebrahim S.B., Ueland P.M., Shaper A.G., Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men, Lancet, 1995, 346, 1395-1398 Google Scholar

[26] Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattström L.E., Ueland P.M., et al., Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project, JAMA, 1997, 277, 1775-1781 Google Scholar

[27] Stampfer M.J., Malinow M.R., Willett W.C., Newcomer L.M., Upson B., Ullmann D., et al., A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians, JAMA, 1992, 268, 877- 881 Google Scholar

[28] Wardlaw J.M., Murray V., Berge E., del Zoppo G., Sandercock P., Lindley R.L., et al., Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis, Lancet, 2012, 379, 2364-2372 Web of ScienceGoogle Scholar

[29] IST-3 collaborative group, Sandercock P., Wardlaw J.M., Lindley R.I., Dennis M., Cohen G., et al., The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial Google Scholar

[IST- 3]): a randomised controlled trial, Lancet, 2012, 379, 2352-2363 Google Scholar

[30] VITATOPS Trial Study Group, The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke, Cerebrovasc. Dis., 2002, 13, 120-126 Google Scholar

[31] Zenoni S.A., Arnoletti J.P., de la Fuente S.G., Recent developments in surgery: minimally invasive approaches for patients requiring pancreaticoduodenectomy, JAMA Surg., 2013, 148, 1154-1157 Google Scholar

[32] Strain J.J., Dowey L., Ward M., Pentieva K., McNulty H., B-vitamins, homocysteine metabolism and CVD, Proc. Nutr. Soc., 2004, 63, 597- 603 Google Scholar

[33] Ullegaddi R., Powers H.J., Gariballa S.E., B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke, Clin. Sci., 2004, 107, 477-484 Google Scholar

[34] Ullegaddi R., Powers H.J., Gariballa S.E., Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke, Eur. J. Clin. Nutr., 2005, 59, 1367- 1373 Google Scholar

[35] Ullegaddi R., Powers H.J., Gariballa S.E., Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial, J. Parenter. Enteral Nutr., 2006, 30, 108- 114 Google Scholar